L2 Mainstream Functions and Solutions in China
L2 Function Research of Major Brands
Solution Suppliers
Driven by market demand and policies, passenger cars equipped with L2 assisted driving functions have been mass-produced, which triggers enthusiastic market response and robust demand.
1. Installations of L2 autonomous driving functions increased by 118.9% year-on-year
In 2020, the automobile market was affected by the economic downturn and COVID-19. From January to November 2020, the number of passenger cars insured in China was 16.136 million, a year-on-year decrease of 7.5%. Among them, there were 2.60 million ones equipped with L2 autonomous driving functions, a year-on-year spike of 118.9%; the installation rate jumped 9.3 percentage points year-on-year to 16.1%. Plus multiple negative factors, installations of L2 autonomous driving functions bucked the trend to grow, with strong market demand.
Total1
Chinese search engine Baidu announced the formal establishment of a smart car company to enter the automotive industry as a vehicle manufacturer.
Chinese car maker Geely Holding Group will become a strategic partner of the new company. Both parties will be based on Geely’s latest pure electric architecture – the Haohan SEA intelligent evolution experience architecture – and carry out close cooperation in smart car manufacturing related fields to jointly build the next generation of smart cars.
From the perspective of Baidu, the newly established Baidu Automobile Company will be independent of the parent company and maintain independent operation.
Baidu will maintain absolute control over it and will export its core technical capabilities in artificial intelligence and autonomous driving, and support its rapid growth.
Total0
Biopharmaceutical companies rush for IPO on Science and Technology Innovation Board
Recently, numerous biopharmaceutical companies such as Nanmo Biology, Jiachuang Biology, Maiwei Biology, Dana Biology, Sailun Biology have applied for IPO on the Sci-tech Innovation Board. The companies are involved in innovative drug development, innovative drug services, original and unique drugs, and in vitro diagnostics Products and many other sub-industries.
According to Wind data, as of December 21, 109 biomedical companies have attempted to list on the Sci-tech Innovation Board, accounting for 22.71% of the 480 companies applying for the Sci-Tech Innovation Board.
Baidu Apollo and Texas Instruments jointly build automotive-grade chips
On December 22, Baidu Apollo announced that it has reached a cooperation with Texas Instruments to incorporate TI’s automotive-grade processors into the design of Apollo’s integrated software and hardware for autonomous driving products.